What's the difference between peliosis and purpura?
Peliosis
Definition:
Example Sentences:
Purpura
Definition:
(n.) A disease characterized by livid spots on the skin from extravasated blood, with loss of muscular strength, pain in the limbs, and mental dejection; the purples.
(n.) A genus of marine gastropods, usually having a rough and thick shell. Some species yield a purple dye.
Example Sentences:
(1) Purpura fulminans is the cutaneous manifestation of acute activation of the clotting mechanism resulting in massive hemorrhage due to an intravascular consumption coagulopathy.
(2) A close correlation between purpuric reaction and drugs was observed in seven cases of chronic pigmented purpura.
(3) The criteria selected by a classification tree method were similar: palpable purpura, age less than or equal to 20 years at disease onset, biopsy showing granulocytes around arterioles or venules, and gastrointestinal bleeding.
(4) The association of idiopathic thrombocytopenic purpura (ITP) and pregnancy is of special therapeutic significance because it increases the risk to mother and infant during labor.
(5) Two cases with brain purpura following Gram-negative septicaemia were examined morphologically and immunohistochemically.
(6) Chronic idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder in which the abnormality in cellular immunity has remained only vaguely defined.
(7) Idiopathic thrombocytopenic purpura (ITP) is more frequently seen in young females than in any other age or sex group.
(8) An eight-day-old girl suffered from purpura fulminans at her four extremities, skull, bladder, ovary and vagina.
(9) Sera from 24 children with Henoch-Schönlein purpura (HSP) and 25 controls were tested for rheumatoid factor (RF) of various isotypes.
(10) The discoveries that in Graves' disease and myasthenia gravis there are IgG antibodies directed against receptors sites are examples of such developments, while "ikiopathic" thrombocytopenic purpura is now accepted as immunological owing to its behaviour during pregnancy.
(11) We attempted to search for any specific change in the immune system during the onset of childhood acute immune thrombocytopenic purpura (ITP) in order to clarify the pathophysiology of acute ITP by examining the lymphocyte subset, lymphocyte blastogenic response, serum complements, and immunoglobulins in 18 patients with childhood acute ITP and 18 controls (control values after normalization).
(12) The hematoma resulted from intraparenchymal bleeding due to Henoch-Schönlein purpura.
(13) Verotoxin-producing E. coli (most frequently E. coli O157) have been implicated in the pathogenesis of diarrhea, hemorrhagic colitis, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
(14) The action of intravenous immunoglobulins (IVIG) in autoimmune diseases, especially in idiopathic thrombocytic purpura seems to be due to Fc-receptor blockade and immunomodifying qualities.
(15) Newborn infants with congenital homozygous protein C deficiency develop catastrophic thrombosis (purpura fulminans) and will not survive beyond the neonatal period without protein C replacement.
(16) The onset of purpura in this patient was during the incubation of rubella before the initiation of immune response, suggesting that in some patients the mechanism of platelet damage in ITP associated with rubella is through a direct effect of the virus, rather than by circulating antibodies.
(17) At autopsy there were scattered purpura on the skin, and the muscles were atrophic and yellowish-grey in color.
(18) 18 patients with proven autoimmune thrombocytopenic purpura (ATP) (group A) were screened for human lymphocyte antigens (HLA) and compared with 13 patients with secondary thrombocytopenic purpura (group B).
(19) Five patients with post-transfusion purpura (four due to Zw(a), one presumably due to HLA antibodies) were treated with intravenous immunoglobulin (IgG) at doses of 0.4 g per kg body weight.
(20) We have investigated the methods for the maintenance of a pregnancy in a patient with thrombotic thrombocytopenic purpura (TTP), said condition, since 1984, having been controlled by a plasma infusion every 3 to 4 weeks.